- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00206193
Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
October 29, 2007 updated by: Atrium Medical Center
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Suzanne HW Vonken, Dr.
- Phone Number: 466825 003145-5766666
- Email: svonken@gmail.com
Study Contact Backup
- Name: F Roumen, Dr.
- Phone Number: 466509 003145-5766666
Study Locations
-
-
Limburg
-
Heerlen, Limburg, Netherlands
- Recruiting
- Atrium medisch centrum
-
Contact:
- Suzanne HW Vonken, Dr.
- Phone Number: 045-5766666(6825)
-
Principal Investigator:
- Suzanne HW Vonken, Dr.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women by whom a termination of pregnancy is desired.
Exclusion Criteria:
- Women with liver/kidney disease
- Women on long-term use of corticosteroids (> 6 months)
- Cardiovascular problems
- Therapy-resistant diabetic women
- Therapy-resistant asthma/bronchitis
- Thalassemia
- Ulcerative colitis
- Peptic ulcer disease
- Glaucoma
- Porphyria
- Allergic reaction to prostaglandin or mifepristone
- Women with a prior caesarian section or women with contractions at the start of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: F Roumen, Dr., Atrium Medisch Centrum, Heerlen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 13, 2005
First Posted (Estimate)
September 21, 2005
Study Record Updates
Last Update Posted (Estimate)
October 30, 2007
Last Update Submitted That Met QC Criteria
October 29, 2007
Last Verified
September 1, 2005
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Gastrointestinal Agents
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormone Antagonists
- Contraceptive Agents, Hormonal
- Contraceptive Agents
- Reproductive Control Agents
- Contraceptives, Oral
- Contraceptive Agents, Female
- Anti-Ulcer Agents
- Contraceptives, Oral, Synthetic
- Abortifacient Agents, Nonsteroidal
- Abortifacient Agents
- Oxytocics
- Luteolytic Agents
- Abortifacient Agents, Steroidal
- Contraceptives, Postcoital, Synthetic
- Contraceptives, Postcoital
- Menstruation-Inducing Agents
- Misoprostol
- Mifepristone
- Sulprostone
Other Study ID Numbers
- TOP-protocol
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abortion, Induced
-
Boston UniversityCompletedAbortion, Induced | Abortion, Second TrimesterUnited States
-
Boston UniversityCompletedAbortion, Induced | Abortion, Second TrimesterUnited States
-
Medstar Health Research InstituteCompleted
-
Planned Parenthood of Greater New YorkCompletedAbortion, InducedUnited States
-
Wolfson Medical CenterUnknown
-
Gynuity Health ProjectsCompletedAbortion, InducedMoldova, Republic of, Tunisia
-
Gynuity Health ProjectsCompleted
-
Gynuity Health ProjectsCentre de Formation et de la Recherche, TunisiaCompleted
-
Gynuity Health ProjectsUniversity of Puerto RicoTerminatedAbortion, InducedPuerto Rico
-
Nilratan Sircar Medical CollegeCompleted
Clinical Trials on misoprostol
-
Aljazeera HospitalKasr El Aini HospitalUnknown
-
Hospital de Clinicas de Porto AlegreCompletedMiscarriage in First TrimesterBrazil
-
Ferring PharmaceuticalsCompletedCervical Ripening | Labor InductionUnited Kingdom
-
Cairo UniversityCompleted
-
Medstar Health Research InstituteSociety of Family PlanningCompletedSecond Trimester AbortionsUnited States
-
Karolinska InstitutetCompletedFirst Trimester Pregnancy | Surgical Termination of PregnancySweden
-
CHA UniversityCompleted
-
Wenzhou Medical UniversityUnknown
-
University of Texas Southwestern Medical CenterCompleted
-
Rajavithi HospitalCompletedTo Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk WomenThailand